Literature DB >> 17452086

Cationic supported lipid bilayers for antigen presentation.

N Lincopan1, N M Espíndola, A J Vaz, A M Carmona-Ribeiro.   

Abstract

Polystyrene sulfate (PSS) particles (301 nm mean diameter) were covered with single cationic dioctadecyldimethylammonium bromide (DDA) bilayers and used for antigen adsorption and presentation. The antigen was a mixture of purified 18/14 Taenia crassiceps proteins (18/14-Tcra). Firstly, the DDA/PSS assembly was characterized at 1mM NaCl and 5 x 10(9) PSS particles/mL over a range of DDA concentrations (0.001-1mM) by means of dynamic light scattering for particle sizing and zeta-potential analysis. 0.01 mM DDA is enough to produce homodisperse and cationic bilayer-covered particles. Secondly, under these experimental conditions, 18/14-Tcra adsorption isotherms onto biomimetic particles or aluminium hydroxide (Al(OH)3) yield limiting adsorption of 0.36 and 1.32 mg protein/mg biomimetic particles or Al(OH)3, respectively. Finally, in mice, superior humoral and cellular immunoresponse from serum IgG and footpad swelling was obtained for antigen/biomimetic particles in comparison to conventional Al(OH)3. Cationic bilayer-covered particles are a novel, highly organized and, possibly, general immunoadjuvant for antigen presentation and subunit vaccine design.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452086     DOI: 10.1016/j.ijpharm.2007.03.014

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Evaluation of three experimental bovine viral diarrhea virus killed vaccines adjuvanted with combinations of Quil A cholesterol and dimethyldioctadecylammonium (DDA) bromide.

Authors:  Julia F Ridpath; Paul Dominowski; Ramasany Mannan; Robert Yancey; James A Jackson; Lucas Taylor; Sangita Mediratta; Robert Eversole; Charles D Mackenzie; John D Neill
Journal:  Vet Res Commun       Date:  2010-09-28       Impact factor: 2.459

2.  Neisseria lactamica antigens complexed with a novel cationic adjuvant.

Authors:  Emanuelle B Gaspar; Andreza S Rosetti; Nilton Lincopan; Elizabeth De Gaspari
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

3.  Cationic Nanostructures as Adjuvants for Vaccines.

Authors:  Ana Maria Carmona-Ribeiro; Beatriz Ideriha Mathiazzi; Yunys Pérez-Betancourt
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Biomimetic nanoparticles: preparation, characterization and biomedical applications.

Authors:  Ana Maria Carmona-Ribeiro
Journal:  Int J Nanomedicine       Date:  2010-04-07

5.  Cationic Biomimetic Particles of Polystyrene/Cationic Bilayer/Gramicidin for Optimal Bactericidal Activity.

Authors:  Gabriel R S Xavier; Ana M Carmona-Ribeiro
Journal:  Nanomaterials (Basel)       Date:  2017-12-02       Impact factor: 5.076

Review 6.  Self-Assembled Antimicrobial Nanomaterials.

Authors:  Ana Maria Carmona-Ribeiro
Journal:  Int J Environ Res Public Health       Date:  2018-07-04       Impact factor: 3.390

7.  Biocompatible Lipid Polymer Cationic Nanoparticles for Antigen Presentation.

Authors:  Yunys Pérez-Betancourt; Bianca de Carvalho Lins Fernandes Távora; Eliana L Faquim-Mauro; Ana Maria Carmona-Ribeiro
Journal:  Polymers (Basel)       Date:  2021-01-07       Impact factor: 4.329

8.  Silica-based cationic bilayers as immunoadjuvants.

Authors:  Nilton Lincopan; Mariana Ra Santana; Eliana Faquim-Mauro; Maria Helena B da Costa; Ana M Carmona-Ribeiro
Journal:  BMC Biotechnol       Date:  2009-01-19       Impact factor: 2.563

9.  Hybrid Nanoparticles of Poly (Methyl Methacrylate) and Antimicrobial Quaternary Ammonium Surfactants.

Authors:  Beatriz Ideriha Mathiazzi; Ana Maria Carmona-Ribeiro
Journal:  Pharmaceutics       Date:  2020-04-10       Impact factor: 6.321

10.  Immunogenicity of antigens from outer membrane vesicles of Neisseria meningitidis associated with bilayer fragment of dioctadecyldimethylammonium in Swiss adult mice.

Authors:  Fabiana Mahylowski Rinaldi; Emanuelle Baldo Gaspar; Luciana Tendolini Brito; Elizabeth De Gaspari
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.